Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.885
+0.025 (1.34%)
At close: Oct 7, 2026, 4:00 PM EDT
1.880
-0.005 (-0.27%)
After-hours: Oct 7, 2026, 5:47 PM EDT
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $80.78 million as of October 7, 2026. That makes Acrivon Therapeutics the world's 26,950th most valuable company and 4,306th in the United States. Its market cap has increased by 34.45% in one year.
Market Cap
80.78M
Enterprise Value
-7.07M
1-Year Change
34.45%
Global Rank
Country Rank
#4,306 United States
Category
ChartMarket Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $80.78M, a decrease of -65.64%. That is a compound annual growth rate of -23.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 80.56M | 5.94% |
| Dec 31, 2025 | 76.05M | -59.43% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Equillium | 89.41M |
| NeurAxis | 89.29M |
| ImmuCell | 88.55M |
| Nutriband | 88.49M |
| Cognition Therapeutics | 87.97M |
| MediciNova | 87.61M |
| Conexeu Sciences | 87.44M |
| Cardiff Oncology | 87.13M |